Levofloxacin vs Tildrakizumab
Levofloxacin vs Tildrakizumab: Overview
This comparison examines the pharmacological differences between Levofloxacin and Tildrakizumab.
Mechanism of Action
Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.
Pharmacokinetics
Half-life: Levofloxacin β 6-8 hours.
Chemical Properties
Molecular Formula: Levofloxacin β C18H20FN3O4.
Molecular Weight: Levofloxacin β 361.3680 g/mol.
Type: Levofloxacin β Small molecule; Tildrakizumab β Antibody.